Interference of the Developing and Toxin Production of Clostridium Botulinum by Lactobacillus Paracasei Subspecies Paracasei

Interference of the Developing and Toxin Production of Clostridium Botulinum by Lactobacillus Paracasei Subspecies Paracasei

Author(s)

Rafael Alfredo Fernández, María Laura Carbone, María Laura Sánchez, Virtudes Pareja, Laura Irene Teresita de Jong, María Isabel Bianco

Download Full PDF Downloads: 265 Views: 612 Pages: 87-93

Volume 2 - October 2013 (10)

Abstract

Infant botulism is an intestinal toxic-infection affecting infants younger than one year of age, and currently in some country is the most important form of human botulism by its frequency of occurrence. It is a rare neuroparalytic disease, but potentially fatal, especially if it is not early diagnosed and properly treated. It is caused by botulinum neurotoxins produced by species of Clostridium, principally C. botulinum. C. botulinum spores are widely distributed in nature, and its most common habitat and natural reservoir is the soil, the main source of contamination for the different forms of botulism. C. botulinum spores have been identified in some foods, such as honey, corn syrup, infant formula and in some medicinal plants. Considering the difficulty to prevent the swallowing of spores, is particularly relevant have adequate arrangements to interfere with colonization and/or toxin formation of C. botulinum in the intestine. Different probiotics have been demonstrated utility against several intestinal pathogens. So, we studied and demonstrated the interference of Lactobacillus paracasei subsp. paracasei on the growth and toxin formation of one strain of C. botulinum type A. Therefore, administering probiotics to infants, perhaps from birth, would be effective in preventing or treating the disease.

Keywords

Botulism, Infant Botulism, Toxin Formation, Inhibition, Probiotics, Lactic Acid Bacteria, Prevention

References

  1. Arnon SS, Midura TF, Damus K, Word RM, Chin J (1978). Intestinal infection and toxin production by Clostridium botulinum as one cause of sudden infant death syndrome. Lancet 1:1273–1277
  2. Arnon SS, Midura TF, Damus K, Thompsom B, Word Rm, Chin J (1979a). Honey and other environmental risk factor for infant botulism. J Pediatr 94: 331-336
  3. Arnon SS, Werner SB, Faber HK, Farr WH (1979b). Infant botulism in 1931: discovery of a misclassified case. Am J Dis Child 133:580-582
  4. Arnon SS, Damus K, Chin J (1981). Infant botulism: Epidemiology and relation to sudden infant death syndrome. Epidemiol Rev 3:45-66
  5. Arnon SS (1998). Infant botulism. In: Feigin RD, eds Textbook of pediatric infectious disease, 4th ed. Philadelphia: WB Saunders. Pg. 1758-66
  6. Bianco MI, Lúquez C, de Jong LI, Fernández RA (2008). Presence of Clostridium botulinum spores in Matricaria chamomilla (chamomile) and its relationship with infant botulism. Int J Food Microbiol 121(3):357-360
  7. Bianco MI, Lúquez C, de Jong LIT, Fernández RA (2009). Linden flower (Tilia spp) as potential vehicle of Clostridium botulinum spores in the transmission of infant botulism. Rev Arg Microbiol 41(4):232-236
  8. Brashears M, Siobhan S, Stanley E (1998). Antagonistic action of cells of Lactobacillus lactis toward Escherichia coli O157: H7 on refrigerated raw chicken meat. J Food Prot 61(2):166-170
  9. Brashears M, Durre W (1999). Antagonistic action of Lactobacillus lactis toward Salmonella spp. and Escherichia coli O157: H7 during growth and refrigerated storage. J Food Prot 62(11):1336-1340
  10. Brett MM, Mclauchlin J, Harris A, O’Brien S, Black N, Forsyth RJ, Roberts D, Bolton FJ (2005). A case of infant botulism with a possible link to infant formula milk powder: evidence for the presence of more than one strain of Clostridium botulinum in clinical specimens and food. J Medical Microbiol 54:769-76
  11. De Genaro MS (2012). Curso Probióticos III. Módulo III: Principios y aplicaciones prácticas. Asociación Argentina de Alergia e Inmunología Clínica
  12. FENS (2011). XI Congreso de la Federación Europea de Sociedades de Nutrición. Simposio “Microbiota & Probiotics: A life long relationship”. JANO.es Se confirman los beneficios de los probióticos frente a las diarreas infantiles, el síndrome del intestino irritable y las infecciones respiratorias. Carla Nieto. Madrid 02 Noviembre 2011
  13. Fernández RA, Ciccarelli AS, Plaza I (1994). Clostridium botulinum en mieles y botulismo del lactante. Boletín de vigilancia epidemiológica. RAVETA 7:20-22
  14. Fernández RA, Ciccarelli AS, Centorbi ONP, Centorbi HJ, Rosetti FA, de Jong LIT, Demo N (1999). Infant botulism in Argentina, 1982-1997. Rev Anaerobe 5:177-179
  15. Fuller R. (1989). Probiotics in man and animal. Journal of Applied Bacteriology 66:365-378
  16. Giménez DF, Ciccarelli AS (1970). Distribución de Clostridium botulinum en Mendoza, Argentina. Bol. Ofic Sanit Panamer 69:505-510
  17. Harrell WK, Green JH & Winn JF (1964). En: Lewis KH, Cassel K (Jr). (Eds) Botulism. Proceeding of Symposium p. 168, US Dep Hlth Educ Welf, Public Hlth Serv Cincinnati, Ohio 45226
  18. Hauschild AHW, Hilsheimer R, Weiss KF, Burke RB (1988). Clostridium botulinum in honey, syrups, and dry infant cereals. Jf Food Protection 51:892–894
  19. Helander I, Von Wright A, Mattila-Sandholm T (1997). Potencial of lactic acid bacteria and novel antimicrobial against Gram negative bacteria. Trends Food Sci Technol 8:146-150
  20. Huhtanen CN, Knox D, Shimanuki H (1981). Incidence and origin of Clostridium botulinum spores in honey. J Food Protec 44:812-815
  21. Kautter DA, Lilly T, Solomon HM, Lynt RK (1982). Clostridium botulinum spores in infant foods: a survey. Journal of Food Protection 45:1028–1029
  22. Koepke R, Sobel J, Arnon SS (2008). Global Occurrence of Infant Botulism, 1976-2006. Pediatrics 122:e73-e82. http://www.pediatrics.org/cgi/content/ full/122/1/e73
  23. Laboratorios Britania. www.britanialab.com.ar/esp/productos/b02/mrsagar.htm
  24. Lúquez C, Bianco MI, de Jong LIT, Sagua MD, Arenas GN, Ciccarelli AS, Fernández RA (2005). Distribution of Botulinum Toxin-Producing Clostridia in Soils of Argentina. Appl Environ Microbiol 71(7):4137–4139)
  25. Lúquez C, Bianco MI, Sagua MD, Barzola CP, de Jong LIT, Degarbo SM, Fernández RA (2007). Relationship between the incidence of infant botulism and the presence of botulinum-toxin producing clostridia in the soil of Argentina from 1982–2005. J Pediatric Neurology 5:279–286
  26. Midura TF, Snowden S, Wood RM, Arnon SS (1979). Isolation of Clostridium botulinum from honey. J Clin Microbiol 9:282-283
  27. Midura TE (1996). Update: Infant botulism. Clin Microbiol Rev 9:119-125
  28. Nakano H, Okaba T, Hashimoto H, Sakaguchi G (1990). Incidence of Clostridium botulinum in honey of various origins. Jpn J Med Sci Biol 43:183-195
  29. Penna FJ (1998). Diarrea y Probióticos. Simposio sobre Utilidad de los probióticos en el manejo de las diarreas. Revista de enfermedades infecciosas en pediatría. Vol XI, número 6, p 182
  30. Radsel A, Andlovic A, Neubauer D, Osredkar D (2013). Infant botulism: First two confirmed cases in Slovenia and literature review. Europ J Paediatric Neurol xxx:I-6. http://dx.doi.org/10.1016/j.ejpn.2013.04.009
  31. Reed LJ, Muench H (1938). A simple method for estimating fifty per cent end-points. Am J Hyg 27:493-497
  32. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH (1994). Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrea and shedding of rotavirus. Lancet 344(8929):1046-1049
  33. Sakaguchi G, Sakaguchi S, Kamata Y, Tabita K, Asao T, Kozaki S (1990). Distinct characters of Clostridium botulinum type A strains and their toxin associated with infant botulism in Japan. Internat J Food Microbiol 11(3-4):231-241
  34. Sobel J (2005). Botulism. Clin Infect Diseases 41(8):1167-1173
  35. Suárez L, Perdomo M, Escobar H (1994). Microflora bacteriana y ecosistema intestinal. Fisiopatología del intestino delgado contaminado. Diarrea aguda. Medio Ambiente en España. GEN, 48 (2): 61-64
  36. Sullivan NM, Mills DC, Riemann HP, Arnon SS (1988). Inhibition of growth of Clostridium botulinum by intestinal microflora isolated from healthy infants. Microb Ecol Health Dis 1(3):179-192
  37. Theodorakopouloua M, Perrosb E, Giamarellos-Bourboulisc EJ, Dimopoulosa G (2013). Controversies in the management of the critically ill: the role of probiotics. Internat J Antimicrobial Agents 42S:S41-S44
  38. Uymaz B, Akkoç N, Akçelik M (2011). Partial characterization of bacteriocins produced by two Lactobacillus strains with probiotic properties. Acta Biol Hung 62(1):95-105

Cite this Article:

International Journal of Sciences is Open Access Journal.
This article is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) License.
Author(s) retain the copyrights of this article, though, publication rights are with Alkhaer Publications.

Issue April 2017

Volume 6, April 2017


Table of Contents


Order Print Copy

World-wide Delivery is FREE

Share this Issue with Friends:


Submit your Paper